Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2010
10/13/2010CN101856335A Azithromycin composite freeze-dried powder for injection
10/13/2010CN101856332A Method for preparing 8, 9-single-epoxy brevifolin PLGA microspheres
10/13/2010CN101856331A Arginine (s)-ibuprofen granules and preparation method thereof
10/13/2010CN101856330A Dry powder type mucosal drug delivery preparation
10/13/2010CN101856327A Aerosol with quantitative inhalation of bencycloquidium bromide and preparation method thereof
10/13/2010CN101856326A Method for preparing medical lycorine emulsion
10/13/2010CN101856325A Hydrochloric acid melphalan injection liquid and preparation method thereof
10/13/2010CN101856323A Beta-CD inclusion suppository containing rana chensinensis antibacterial peptide and preparation method thereof
10/13/2010CN101856322A Sulfadiazine silver controlled-release gel and preparation method thereof
10/13/2010CN101856321A Oral dry gels
10/13/2010CN101632681B Glycerol fructose liposome drug combination injection and preparation method thereof
10/13/2010CN101530393B Clindamycin phosphate lipidosome freeze-dried preparation
10/13/2010CN101401793B Capsule type inhalation dust cloud agent
10/13/2010CN101396366B Solid oral preparation containing valsartan and preparation method thereof
10/13/2010CN101342152B Butylbenzene phthalein tablet and preparation method thereof
10/13/2010CN101327213B 厄贝沙坦氢氯噻嗪药用组合物及其制备方法 Irbesartan Hydrochlorothiazide pharmaceutical composition and its preparation method
10/13/2010CN101322712B Alprostadil nano granule formulation and preparation thereof
10/13/2010CN101317847B Medicament composition for eyes or nose, and uses thereof
10/13/2010CN101278908B Eye drop capable of significantly increasing medicament effect
10/13/2010CN101240031B Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application
10/13/2010CN101239052B Method for preparing sodium alginate/ chitosan sustained-release microcapsule by external gelation
10/13/2010CN101219144B Long-circulation nano-grain of hydroxycamptothecin and method for preparing the same
10/13/2010CN101180047B Use of cyclodextrin complexes containing lipoic acid
10/13/2010CN101171038B The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
10/13/2010CN101152170B Capsule containing pseudoephedrine and method for preparing the same
10/13/2010CN101143212B Recombination human acidic mechanocyte growth factor temperature sensitive type gel preparation and preparation method thereof
10/13/2010CN101099738B Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation
10/13/2010CN101095693B Compound recipe medicine for treating dermatitis
10/13/2010CN101019869B Medicine composition of alprostadil and Chuanhuning/Yanhuning liposome and its preparation
10/12/2010US7812152 Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof
10/12/2010US7812120 Nasal calcitonin formulations containing chlorobutanol
10/12/2010US7812000 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
10/12/2010US7811982 Compounds and methods for treating cancer
10/12/2010US7811797 producing cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811605 If the hydrogel particles are sufficiently small, substances dispersed in them will diffuse to the surface and be released at essentially the same rate
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811559 Administering to the patient an amount of CLN2 protein (Neuronal ceroid lipofuscinoses (NCLs)) effective to reduce or eliminate the symptoms caused by the deficiencyl in CLN2 protein; Central nervous system disorders
10/12/2010US7811556 polyoxyethylene glycol-allylmethyldiether-maleic acid sodium salt copolymers with fibroblast growth factors; improved conjugation, crosslinking between polymer and protein; formed via hydrolysis, ammonolysis, aminolysis and alcoholysis of anhydride moieties
10/12/2010US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/12/2010CA2620738C Tablet for removing tongue coating
10/12/2010CA2494157C Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof
10/12/2010CA2456356C Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
10/12/2010CA2439097C Pharmaceutical compositions
10/12/2010CA2438657C Testosterone-containing transdermal therapeutic system and process for its production
10/12/2010CA2425420C Administration of resveratrol to treat inflammatory respiratory disorders
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2375599C Probiotic compositions comprising e. coli and volatile fractions of plant extracts
10/12/2010CA2374933C Grf-containing lyophilized pharmaceutical compositions
10/12/2010CA2320402C Modified ciliary neurotrophic factor, method of making and methods of use thereof
10/12/2010CA2316032C Absorbable copolylactides and their use
10/12/2010CA2300176C Latent reactive polymers with biologically active moieties
10/12/2010CA2230925C Fusion protein delivery system and uses thereof
10/10/2010CA2699180A1 Patch and patch preparation
10/09/2010CA2697576A1 Granulate for the formulation of orodispersible tablets
10/07/2010WO2010115015A1 Modified-release pharmaceutical drug composition
10/07/2010WO2010114982A2 Lyophilization cakes of proteasome inhibitors
10/07/2010WO2010114710A2 An artificial micro-gland
10/07/2010WO2010114539A1 Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides
10/07/2010WO2010114445A1 Plant fiber product and method for its manufacture
10/07/2010WO2010114134A1 Hard capsule
10/07/2010WO2010114121A1 Aqueous gel base and aqueous gel plaster
10/07/2010WO2010114074A1 Hyperbranched polyoxyalkylene compound and method for producing same
10/07/2010WO2010114013A1 Polyion complex of double-stranded ribonucleic acid
10/07/2010WO2010113984A1 Liposome composition
10/07/2010WO2010113983A1 Method for producing liposome composition
10/07/2010WO2010113960A1 Agent for inhibiting thickening of peritoneal membrane
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113840A1 Solid pharmaceutical composition containing amorphous body of solifenacin
10/07/2010WO2010113800A1 Dentine calcification agent and method for producing same
10/07/2010WO2010113785A1 Method for producing sugar composition containing definite amount of target hexose and having sugar composition ratio different from starting sugar material, and use of sugar composition thus produced
10/07/2010WO2010113688A1 Composition for oral cavity
10/07/2010WO2010113325A1 Pectin-containing jelly preparation
10/07/2010WO2010113324A1 Pectin-containing jelly preparation
10/07/2010WO2010113225A1 Riluzole-containing transdermal patch
10/07/2010WO2010113157A1 Lipopeptide inhibitors of hiv-1
10/07/2010WO2010113151A1 Conjugated antimicrobial agents
10/07/2010WO2010113111A1 Method for preparing functionalized lipid capsules
10/07/2010WO2010112829A1 Intimate lubrication kit
10/07/2010WO2010112753A1 Novel thickening polymer in the form of a powder
10/07/2010WO2010112658A1 Macroporous or meso/macroporous polymer materials produced in concentrated and highly concentrated emulsions
10/07/2010WO2010112411A1 Co-crystal of etravirine and nicotinamide
10/07/2010WO2010111807A1 A polysaccharide liposome, the preparation method and use of it
10/07/2010WO2010111759A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin
10/07/2010WO2010080754A3 Nanoparticle pharmaceutical formulations
10/07/2010WO2010034901A3 Gel adapted for transmitting ultrasound waves, method for making said gel, and bag containing same
10/07/2010WO2010027479A3 Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids
10/07/2010US20100256671 Tissue sealant for use in noncompressible hemorrhage
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100255558 Supramolecular bioconjugates
10/07/2010US20100255100 Stabilized protein crystals, formulations comprising them and methods of making them
10/07/2010US20100255098 Stereocomplex hydrogels
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255073 Composition for transdermal delivery of fentanyl
10/07/2010US20100255062 Compounds, polymers and methods for treating gastrointestinal dysfunction
10/07/2010US20100255014 Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation Thereof
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010US20100254961 Water-soluble electrospun sheet
10/07/2010US20100254917 Organic nano-particles and process for their preparation
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1712